Events And
Presentations

GLP-1-Based Therapeutics Summit

May 16, 2024 at 1:30 PM EDT

Title: Attaining Product Differentiation through Improved Patient Segmentation & Efficiency

Speaker: Dr. Scott Harris, Chief Medical Officer, Altimmune

Supporting Materials

Location

Philadelphia, PA
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe